BD Acquires TVA Medical To Advance Chronic Kidney Disease Solutions
Jul 9, 2018 @ 13:25

TVA Medical’s everlinQ endoAVF System also received FDA De Novo marketing authorization.

Sourced through Scoop.it from: www.mpo-mag.com

Leave a Reply